Regional Prospective Observational Research for Tuberculosis

Study Sites

RePORT-Brazil Study Sites

Collaborating Institutions in Rio de Janeiro, Brazil

Rio de Janeiro has a population of 6 million people, and the highest incidence of TB in Brazil (74/100,000). However, within the lowest-income areas the incidence rate can be as high as 400/100,000. The city is sub-divided into ten major administrative areas, each of which is sub-divided into administrative regions. Each of these has at least one municipal primary care health clinic at which TB patients receive free medical assistance and treatment.

The four centers and their related clinics and hospitals are located in the eastern part of the city within 10 km of each other, and near major expressways (see map – UFRJ (red), INI (yellow), Rocinha (blue) and Duque de Caxias (green)).

Collaborating Institutions in Salvador, Brazil

Instituto Brasileiro de Investigacao da Tuberculose (IBIT) and Instituto Bahiano de Reabilitacao (IBR), Fundacao Jose Silveira (FJS)
Salvador, Bahia, Brasil

IMU-LIMI-CPqGM-FIOCRUZ, Salvador
The Investigative Medicine Unit (IMU) is an advanced laboratory facility within the Laboratório Integrado de Microbiologia e Imunorregulação (LIMI) at the Centro de Pesquisas Gonçalo Moniz (CPqGM), Fundação Oswaldo Cruz (FIOCRUZ), located in Salvador.

 

Collaborating Institutions in Manaus, Brazil

Fundacao de Medicina Tropical (FMT)
Manaus, Amazonas, Brasil

FMT is a referral center for the diagnosis and treatment of infectious, parasitic and dermatological diseases, admitting in their facilities patients referred by the health network of Manaus and from the countryside of the Amazonas State, as well as from neighboring states and countries.

 

Coordinating Center

Vanderbilt Tuberculosis Center (VTC)
The Vanderbilt Tuberculosis Center was established in 2012 to expand the Vanderbilt global research portfolio in tuberculosis (TB) and HIV-related TB, with a focus on epidemiology, clinical trials, and translational research. The Vanderbilt Tuberculosis Center includes investigators from across the university, as well as local, regional, and global collaborators. The Center focuses on four broad areas of research:
1. TB/HIV Co-Infection
2. TB Drug Resistance
3. TB Treatment and Prevention
4. M. tuberculosis transmission and Pathogenesis
The Center has an emphasis on developing and mentoring junior faculty members, fellows, and students from Vanderbilt University, Meharry Medical College, and collaborating health departments and international institutions, particularly RePORT-Brazil institutions. The Center also provides technical assistance to the Vanderbilt-linked global and local service programs engaged in TB control: the Metro Nashville Public Health Department, the Tennessee Department of Health, and PEPFAR/Global Health Initiatives in Africa, Asia, and the Americas.

Contact

For comments or questions, please contact:

Marina Cruvinel Figueiredo, Program Manager
Vanderbilt University Medical Center, marina.cruvinel.figueiredo@vumc.org

Funders

RePORT-Brazil acknowledges funding from the National Institutes of Health (NIH) (the National Institute of Allergy and Infectious Diseases (NIAID)), CRDF Global, Departamento de Ciencia e Tecnologia (DECIT)- Secretaria de Ciencia e Tecnologia (SCTIE) of the Ministry of Health of Brazil.